Hamostaseologie 2019; 39(S 02): S01-S10
DOI: 10.1055/s-0039-3400724
Hämophilie Teil II
Georg Thieme Verlag KG Stuttgart · New York

Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study

Katharina Holstein
1   II. Medizinische Klinik, Universitätsklinikum Hamburg- Eppendorf, Hamburg, Hamburg, Germany
,
Leonora Witt
2   Universitätsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
,
Tim Rolvien
3   Institut für Osteologie und Biomechanik, Ambulanzzentrum des UKE, Hamburg, Hamburg, Germany
,
Tobias Schmidt
3   Institut für Osteologie und Biomechanik, Ambulanzzentrum des UKE, Hamburg, Hamburg, Germany
,
Michael Amling
3   Institut für Osteologie und Biomechanik, Ambulanzzentrum des UKE, Hamburg, Hamburg, Germany
,
Florian Barvencik
3   Institut für Osteologie und Biomechanik, Ambulanzzentrum des UKE, Hamburg, Hamburg, Germany
,
Anna Matysiak
2   Universitätsklinikum Hamburg-Eppendorf, Hamburg, Hamburg, Germany
,
Florian Langer
1   II. Medizinische Klinik, Universitätsklinikum Hamburg- Eppendorf, Hamburg, Hamburg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
20 November 2019 (online)

 

Background: Reduced bone mineral density (BMD) has been observed as a common comorbidity in patients with haemophilia (PWH). Our aim was to describe the prevalence of reduced BMD in PWH in Northern Germany and to further determine the bone microstructure and contributing factors to possible bone alterations.

Methods: BMD, bone microstructure, laboratory parameters of bone metabolism, pain and orthopaedic joint status (OJS) were assessed routinely during check-ups. BMD was assessed by dual energy X-Ray absorptiometry (DXA) and bone microstructure by high-resolution peripheral quantitative computed tomography (HR-pQCT). Patients completed questionnaires on their activity and lifestyle.

Results: So far, data of 75 PWH (median age 33 years, range 18–77) could be retrospectively analysed, of whom 62 had haemophilia A and 13 haemophilia B. 54 PWH (72%) had severe, 7 (9%) moderate, 14 (19%) mild haemophilia, 7 patients (9%) had a previous inhibitor. Mean BMI was 25.7 } 3.9 kg/m2, and mean vitamin D level was 16.9 } 7.5 μg/l; 69 PWH (92%) had vitamin D deficiency (<30 μg/l), 15 (20%) severe deficiency (<10 μg/l). 12 PWH (16%) had osteoporosis, and 35 (46.1%) osteopenia, as defined by a T-score of ≤−2.5 and <−1.0 (hip or spine), respectively. Among the 3 groups (normal BMD, osteopenia, osteoporosis), an association was found to BMI, OJS, Haemophilia Activities List (HAL) (PWH with osteoporosis had lower BMI, p = 0.041, higher OJS, p<0.01, lower HAL, p = 0.012) while no differences were found regarding treatment regimen and sport. All patients with a previous inhibitor (n = 7) had osteopenia or osteoporosis. Of PWH, 39% had an impaired bone microstructure at the distal radius, and 45% at the tibia. In the radius 32% had isolated reduced cortical thickness (<70% of the age and gender matched mean), 3% a trabecular deficit and 7% a combined. In the tibia, 27% had an isolated trabecular, 7% a cortical and 12% a combined bone structural deficit. Regarding markers for bone metabolism, in PWH with osteoporosis a higher level of osteocalcin was observed (p = 0.036).

Conclusion: Reduced BMD is common in our population of PWH in Northern Germany. An association to having a previous inhibitor, worse joint status and physical function was observed. Interestingly, bone structure deficits in radius are dominated by reduced cortical thickness whereas in the tibia a trabecular or combined structural deficit predominates, suggesting different pathophysiological mechanisms.